JP2022520997A5 - - Google Patents
Info
- Publication number
- JP2022520997A5 JP2022520997A5 JP2021549213A JP2021549213A JP2022520997A5 JP 2022520997 A5 JP2022520997 A5 JP 2022520997A5 JP 2021549213 A JP2021549213 A JP 2021549213A JP 2021549213 A JP2021549213 A JP 2021549213A JP 2022520997 A5 JP2022520997 A5 JP 2022520997A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962809140P | 2019-02-22 | 2019-02-22 | |
| US62/809,140 | 2019-02-22 | ||
| US201962908105P | 2019-09-30 | 2019-09-30 | |
| US62/908,105 | 2019-09-30 | ||
| PCT/US2020/019142 WO2020172485A1 (en) | 2019-02-22 | 2020-02-21 | Methods of using imipridones |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022520997A JP2022520997A (ja) | 2022-04-04 |
| JPWO2020172485A5 JPWO2020172485A5 (https=) | 2023-02-20 |
| JP2022520997A5 true JP2022520997A5 (https=) | 2023-02-20 |
Family
ID=72144740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549213A Pending JP2022520997A (ja) | 2019-02-22 | 2020-02-21 | イミプリドンを使用する方法 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20220143024A1 (https=) |
| JP (1) | JP2022520997A (https=) |
| WO (1) | WO2020172485A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020228047B2 (en) * | 2019-02-27 | 2025-11-20 | Madera Therapeutics, LLC | Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents |
| EP4337214A4 (en) * | 2021-05-13 | 2025-01-29 | Chimerix, Inc. | USES AND METHODS FOR RECURRENT PRIMARY CNS NEOPLASMAS |
| CN115448921B (zh) * | 2021-06-08 | 2023-08-01 | 四川大学 | 一类咪唑烷并嘧啶酮化合物及在治疗HsClpP介导的疾病中的用途 |
| CN115611896A (zh) * | 2021-07-16 | 2023-01-17 | 中国药科大学 | 含四氢萘啶酮或四氢吡啶并嘧啶酮骨架的化合物及其制备方法与制药用途 |
| WO2024199457A1 (zh) * | 2023-03-31 | 2024-10-03 | 苏州安赛隆医药科技有限公司 | 并环结构化合物、其制备方法及其用途以及药物组合物及其用途 |
| WO2024218275A1 (en) * | 2023-04-20 | 2024-10-24 | Institut Gustave Roussy | Liquid and solid compositions of imipridone derivatives |
| WO2025250553A1 (en) * | 2024-05-28 | 2025-12-04 | Chimerix, Inc. | Solid state forms of imipridone derivative |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9925251B2 (en) * | 2011-10-19 | 2018-03-27 | President And Fellows Of Harvard College | Treatments for Mycobacterium tuberculosis |
| PL3408298T3 (pl) * | 2016-01-29 | 2025-03-31 | Oncoceutics, Inc. | Modulacja przez imiprydony receptora sprzężonego z białkiem g (gpcr) |
| US10172862B2 (en) * | 2017-01-30 | 2019-01-08 | Oncoceutics, Inc. | Imipridones for gliomas |
-
2020
- 2020-02-21 US US17/432,633 patent/US20220143024A1/en not_active Abandoned
- 2020-02-21 JP JP2021549213A patent/JP2022520997A/ja active Pending
- 2020-02-21 WO PCT/US2020/019142 patent/WO2020172485A1/en not_active Ceased